Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir

被引：0
|
作者：
Danielle Perez-Bercoff
Perrine Triqueneaux
Christine Lambert
Aboubacar Alassane Oumar
Anne-Marie Ternes
Sounkalo Dao
Patrick Goubau
Jean-Claude Schmit
Jean Ruelle
机构：
[1] CRP-Santé,Laboratoire de Rétrovirologie
[2] AIDS Reference Laboratory,UCLouvain
[3] de Pharmacie et d'Odontostomatologie de Bamako,Faculté de Médecine
[4] International center of Excellence Research Mali (ICER-Mali),undefined
来源：
Retrovirology | / 7卷
关键词：
Human Immunodeficiency Virus Type; Raltegravir; Replicative Capacity; Elvitegravir; I175M Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] HIV-2 Antiviral Potency and Selection of Drug Resistance Mutations by the Integrase Strand Transfer Inhibitor Elvitegravir and NRTIs Emtricitabine and Tenofovir In Vitro
    Andreatta, Kristen
    Miller, Michael D.
    White, Kirsten L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (04) : 367 - 374
  • [22] Raltegravir, an HIV-1 integrase inhibitor for HIV infection
    Cabrera, Cecilia
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (08) : 885 - 898
  • [23] Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy
    Charpentier, C.
    Karmochkine, M.
    Laureillard, D.
    Tisserand, P.
    Belec, L.
    Weiss, L.
    Si-Mohamed, A.
    Piketty, C.
    HIV MEDICINE, 2008, 9 (09) : 765 - 770
  • [24] Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc
    Armstrong-James, Darius
    Stebbing, Justin
    Scourfield, Andrew
    Smit, Erasmus
    Ferns, Bridget
    Pillay, Deenan
    Nelson, Mark
    ANTIVIRAL RESEARCH, 2010, 86 (02) : 224 - 226
  • [25] Raltegravir treatment response in an HIV-2 infected patient: a case report
    Garrett, Nigel
    Xu, Li
    Smit, Erasmus
    Ferns, Bridget
    El-Gadi, Saleh
    Anderson, Jane
    AIDS, 2008, 22 (09) : 1091 - 1092
  • [26] HIV resistance to raltegravir
    Clavel F.
    European Journal of Medical Research, 14 (Suppl 3) : 47 - 54
  • [27] Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2
    Kiarie, Irene Wanjiru
    Hoffka, Gyula
    Laporte, Manon
    Leyssen, Pieter
    Neyts, Johan
    Tozser, Jozsef
    Mahdi, Mohamed
    VIRUSES-BASEL, 2024, 16 (10):
  • [28] Raltegravir: The First HIV Type 1 Integrase Inhibitor
    Hicks, Charles
    Gulick, Roy M.
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (07) : 931 - 939
  • [29] Raltegravir: first integrase inhibitor for the treatment of HIV infection
    Makinson, Alain
    Reynes, Jacques
    FUTURE VIROLOGY, 2009, 4 (01) : 23 - 34
  • [30] Phenotypic assays of 5 integrase inhibitors on HIV-2 clinical isolates reveal a new resistance pathway
    Le Hingrat, Q.
    Collin, G.
    Peytavin, G.
    Visseaux, B.
    Bertine, M.
    Tubiana, R.
    Karmochkine, M.
    Valin, N.
    Lemaignen, A.
    Bernard, L.
    Damond, F.
    Matheron, S.
    Descamps, D.
    Charpentier, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 138 - 139
12345